Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Falender, Rebecca A. ; Mitchell, Paul G. ; Guzman-Cottrill, Judith A. ; Cieslak, Paul R. ; Sutton, Melissa
• Description:
  We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020-December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%-46.5%). We observed no increase in the seroprevalence trend after widespread school reopening. Seroprevalence estimates complement case-based cumulative incidence.
• Subjects:
  Antibodies, Viral Child COVID-19 Dispatch Humans Oregon Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020—June 30, 2022 SARS-CoV-2 Schools Seroepidemiologic Studies
• Source:
  Emerg Infect Dis. 2023; 29(8):1672-1675
• Pubmed ID:
  37486347
• Pubmed Central ID:
  PMC10370852
• Document Type:
  Journal Article
• Funding:
  NU38OT000297/CC/CDC HHSUnited States/
• Volume:
  29
• Issue:
  8
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:969579e0e4355cc134f76902bbf28d94579fe6de8973de953c488d1d711217f9
• Download URL:
  https://stacks.cdc.gov/view/cdc/132628/cdc_132628_DS1.pdf
• File Type:
  [PDF - 1.90 MB ]